Innoviva (INVA) Financials

$19.64 +0.15 (+0.77%)

Closing price 04:00 PM Eastern

Extended Trading

$19.52 -0.12 (-0.61%)

As of 04:58 PM Eastern

Annual Income Statements for Innoviva

This table shows Innoviva's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Income / (Loss) Attributable to Common Shareholders	23	180	214	266	224	157	395	134	119	-19	-168
Consolidated Net Income / (Loss)	23	180	220	369	294	191	406	134	119	-19	-168
Net Income / (Loss) Continuing Operations	23	180	220	369	294	191	406	134	60	-19	-74
Total Pre-Tax Income	37	194	287	445	354	233	210	134	60	-19	-74
Total Operating Income	43	202	320	466	371	246	238	184	109	32	-34
Total Gross Profit	322	268	318	392	337	261	261	217	134	54	8.43
Total Revenue	359	310	331	392	337	261	261	217	134	54	8.43
Operating Revenue	359	310	331	392	337	261	261	217	134	54	8.43
Total Cost of Revenue	37	43	14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cost of Revenue	37	43	14	0.00	0.00	-	-	-	-	-	-
Total Operating Expenses	279	65	-2.86	-74	-35	15	23	34	25	22	42
Selling, General & Admin Expense	116	98	64	16	14	15	23	32	23	20	35
Research & Development Expense	14	34	41	0.58	1.79	0.00	0.00	1.36	1.39	2.62	7.50
Amortization Expense	26	22	5.58	0.00	0.00	-	-	-	-	-	-
Other Operating Expenses / (Income)	123	-89	-113	-91	-50	-	-	-	-	-	-
Total Other Income / (Expense), net	-6.07	-8.31	-33	-21	-17	-13	-28	-49	-49	-50	-40
Interest Expense	22	19	36	19	18	19	24	44	52	52	37
Interest & Investment Income	19	16	6.37	1.84	1.52	5.54	1.66	1.31	0.58	0.34	0.56
Other Income / (Expense), net	-3.00	-4.97	-3.37	-3.63	-0.35	-0.35	-5.70	-7.04	2.48	1.12	-3.27
Income Tax Expense	14	14	67	76	60	42	-196	0.00	0.10	-	-
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.00	6.34	103	69	34	11	0.13	0.00	0.00	-
Basic Earnings per Share	$0.37	$2.75	$3.07	$3.24	$2.21	$1.55	$3.92	$1.25	$0.54	($0.16)	($1.50)
Weighted Average Basic Shares Outstanding	62.73M	65.44M	69.64M	82.06M	101.32M	101.15M	100.85M	106.95M	110.28M	115.37M	112.06M
Diluted Earnings per Share	$0.36	$2.20	$2.37	$2.87	$2.02	$1.43	$3.53	$1.17	$0.53	($0.16)	($1.50)
Weighted Average Diluted Shares Outstanding	74.19M	86.88M	95.25M	94.31M	113.55M	113.41M	113.41M	119.87M	123.23M	115.37M	112.06M
Weighted Average Basic & Diluted Shares Outstanding	62.68M	63.23M	68.13M	69.57M	101.39M	101.30M	101.12M	107.30M	110.30M	117.30M	112.06M

This table shows Innoviva's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-47	20	1.21	-35	37	62	82	1.28	35	-68	266
Consolidated Net Income / (Loss)	-47	20	1.21	-35	37	62	82	1.28	35	-68	229
Net Income / (Loss) Continuing Operations	-47	20	1.21	-35	37	62	82	1.28	35	-68	229
Total Pre-Tax Income	-39	25	6.85	-39	45	61	86	5.81	41	-65	286
Total Operating Income	41	24	8.07	-36	48	63	87	8.53	44	-41	289
Total Gross Profit	73	85	80	91	67	73	57	72	66	56	64
Total Revenue	89	92	90	100	77	86	67	81	76	66	67
Operating Revenue	89	92	90	100	77	86	67	81	76	66	67
Total Cost of Revenue	15	7.17	9.99	8.47	11	13	10	8.98	10	10	3.68
Operating Cost of Revenue	15	7.17	9.99	8.47	11	13	10	8.98	10	10	3.68
Total Operating Expenses	32	61	71	127	19	9.66	-30	63	22	96	-226
Selling, General & Admin Expense	27	31	26	28	30	26	29	24	20	17	28
Research & Development Expense	4.40	3.67	3.55	2.56	3.88	2.36	3.99	15	13	9.99	12
Total Other Income / (Expense), net	-80	1.15	-1.22	-3.30	-2.69	-1.85	-1.33	-2.73	-2.41	-24	-2.93
Interest Expense	4.71	4.75	5.81	5.80	5.85	5.95	4.40	4.38	4.43	25	5.10
Interest & Investment Income	-9.01	5.77	5.50	3.47	4.40	4.79	4.11	3.55	3.37	3.19	2.14
Other Income / (Expense), net	-66	0.13	-0.91	-0.97	-1.24	-0.68	-1.05	-1.90	-1.35	-2.62	0.03
Income Tax Expense	8.00	4.36	5.64	-4.59	8.59	-0.33	3.91	4.53	6.28	3.63	57
Basic Earnings per Share	($0.74)	$0.32	$0.02	($0.55)	$0.58	$0.96	$1.26	$0.02	$0.51	($0.98)	$3.81
Weighted Average Basic Shares Outstanding	62.71M	62.73M	62.57M	62.53M	63.19M	65.44M	64.95M	65.34M	67.79M	69.64M	69.73M
Diluted Earnings per Share	($0.74)	$0.43	$0.02	($0.55)	$0.46	$0.78	$0.98	$0.02	$0.42	($0.68)	$2.80
Weighted Average Diluted Shares Outstanding	62.71M	74.19M	62.95M	62.53M	84.53M	86.88M	86.16M	65.49M	89.79M	95.25M	95.83M
Weighted Average Basic & Diluted Shares Outstanding	62.78M	62.68M	62.60M	62.56M	62.44M	63.23M	64.09M	65.10M	65.50M	68.13M	69.78M

This table details how cash moves in and out of Innoviva's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Change in Cash & Equivalents	111	-98	90	-45	-32	216	-11	-45	-41	62	-47
Net Cash From Operating Activities	189	141	202	364	313	257	224	142	61	10	-131
Net Cash From Continuing Operating Activities	189	141	202	364	313	257	224	142	61	10	-131
Net Income / (Loss) Continuing Operations	23	180	220	369	294	191	406	134	60	-19	-168
Consolidated Net Income / (Loss)	23	180	220	369	294	191	406	134	60	-19	-168
Depreciation Expense	14	14	14	14	14	14	14	14	14	14	12
Amortization Expense	28	24	7.64	9.14	7.92	5.25	7.17	4.69	2.65	3.53	4.15
Non-Cash Adjustments To Reconcile Net Income	143	-56	-72	-88	-49	2.38	8.98	17	6.81	28	52
Changes in Operating Assets and Liabilities, net	-20	-20	32	60	46	45	-213	-28	-22	-17	-30
Net Cash From Investing Activities	-64	-67	-57	44	-315	-18	3.52	-23	-4.58	159	-65
Net Cash From Continuing Investing Activities	-64	-67	-57	44	-315	-18	3.52	-23	-4.58	159	-65
Purchase of Property, Plant & Equipment	-0.27	-0.41	-0.07	0.00	-0.01	-0.01	0.00	0.00	-0.28	-0.01	-0.69
Acquisitions	-4.00	0.00	-204	-44	0.00	-	-	-	-	-	-
Purchase of Investments	-135	-139	-98	66	-401	-232	-72	-68	-96	-87	-277
Sale of Property, Plant & Equipment	0.10	0.00	0.00	-	-	-	-	-	-	-	0.14
Divestitures	0.00	0.00	23	0.00	0.00	-	-	-	-	-	-
Sale and/or Maturity of Investments	76	73	24	21	86	214	75	44	91	246	347
Other Investing Activities, net	0.00	0.00	198	0.00	0.00	0.00	-	-	-	-	-134
Net Cash From Financing Activities	-13	-172	-56	-452	-30	-24	-238	-163	-98	-107	149
Net Cash From Continuing Financing Activities	-13	-172	-56	-452	-30	-24	-238	-163	-98	-107	149
Repayment of Debt	0.00	-96	-165	0.00	0.00	-14	-230	-506	-6.83	0.00	0.00
Repurchase of Common Equity	-15	-76	-8.50	-394	0.00	0.00	-	-98	-78	-26	0.00
Payment of Dividends	0.00	0.00	-70	-59	-30	-11	-6.04	-0.26	-0.96	-87	-335
Issuance of Debt	0.00	0.00	253	0.00	0.00	-	-	443	0.00	0.00	435
Issuance of Common Equity	1.47	0.17	0.37	1.17	0.44	0.63	1.14	0.44	0.39	8.24	55
Other Financing Activities, net	-0.14	-0.08	-65	-0.06	0.25	-0.09	-3.07	-2.13	-0.50	-2.19	-5.66
Cash Interest Paid	10	11	12	9.93	9.93	11	18	40	49	26	9.21
Cash Income Taxes Paid	12	0.00	54	0.00	0.00	-	-	-	-	-	-

This table details how cash moves in and out of Innoviva's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	14	44	44	39	-15	14	6.97	29	-147	-9.78	17
Net Cash From Operating Activities	49	59	49	44	37	33	44	38	26	8.90	16
Net Cash From Continuing Operating Activities	49	59	49	43	37	33	44	38	26	8.90	16
Net Income / (Loss) Continuing Operations	-47	20	1.21	-35	37	62	82	1.28	35	-68	229
Consolidated Net Income / (Loss)	-47	20	1.21	-35	37	62	82	1.28	35	-68	229
Depreciation Expense	3.49	3.49	3.48	3.48	3.51	3.48	3.48	3.48	3.48	3.48	3.36
Amortization Expense	7.02	7.04	7.04	6.96	6.97	7.03	7.03	5.47	4.33	4.63	2.07
Non-Cash Adjustments To Reconcile Net Income	82	23	38	98	-15	-15	-64	32	-8.76	97	-261
Changes in Operating Assets and Liabilities, net	2.66	5.80	-0.36	-30	5.26	-24	16	-3.59	-8.23	-28	42
Net Cash From Investing Activities	-35	-15	-5.27	-	-43	-5.15	-26	-	-36	-8.68	98
Net Cash From Continuing Investing Activities	-35	-15	-5.27	-	-43	-5.15	-26	-	-36	-8.68	98
Purchase of Investments	-55	-34	-52	-0.63	-48	-38	-63	-1.19	-37	8.67	-55
Sale of Property, Plant & Equipment	0.00	0.00	-	-	0.10	-	-	-	0.00	-	-
Sale and/or Maturity of Investments	20	23	47	0.63	5.34	33	37	1.19	1.29	41	55
Net Cash From Financing Activities	0.18	0.57	0.21	-5.07	-9.17	-15	-11	-9.21	-137	-10	-96
Net Cash From Continuing Financing Activities	0.18	0.57	0.21	-5.07	-9.17	-15	-11	-9.21	-137	-10	-96
Repurchase of Common Equity	0.00	-	-	-5.21	-9.57	-15	-11	-9.29	-41	-8.50	-
Issuance of Common Equity	0.25	0.59	0.23	0.16	0.49	0.06	-	0.11	0.00	0.03	0.00
Other Financing Activities, net	-0.07	-0.02	-0.02	-0.02	-0.08	-0.01	-0.01	-0.03	-0.02	-1.53	-42
Cash Interest Paid	5.18	-	5.18	-	5.18	-	5.18	-	6.20	-	6.33

This table presents Innoviva's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Total Assets	1,301	1,244	1,231	926	1,000	725	548	367	379	409	522
Total Current Assets	554	344	444	314	342	431	199	200	198	214	252
Cash & Equivalents	305	194	291	202	246	278	62	73	118	159	97
Short-Term Investments	108	0.00	-	-	-	73	52	56	32	28	144
Note & Lease Receivable	66	70	55	111	-	-	-	-	-	-	-
Accounts Receivable	20	14	9.40	0.00	94	79	83	71	47	26	-
Inventories, net	34	41	56	0.00	-	-	-	-	-	-	-
Prepaid Expenses	21	22	30	1.37	1.64	0.96	0.85	0.75	0.77	0.81	1.13
Other Current Assets	0.66	4.26	2.93	0.07	-	-	-	-	-	-	11
Plant, Property, & Equipment, net	0.51	0.48	0.17	0.01	0.03	0.03	0.16	0.21	0.37	0.22	0.32
Total Noncurrent Assets	746	899	788	613	657	294	349	167	181	194	269
Long-Term Investments	394	561	403	484	438	0.00	-	-	-	-	43
Goodwill	18	18	27	0.00	-	-	-	-	-	-	-
Intangible Assets	208	230	253	0.00	-	-	-	-	-	-	-
Noncurrent Deferred & Refundable Income Taxes	12	0.00	-	17	94	154	196	0.00	-	-	-
Other Noncurrent Operating Assets	114	90	105	112	125	139	153	167	181	194	226
Total Liabilities & Shareholders' Equity	1,301	1,244	1,231	926	1,000	725	548	367	379	409	522
Total Liabilities	610	569	666	400	392	383	389	610	732	752	745
Total Current Liabilities	236	38	135	5.81	6.11	5.37	5.70	35	20	13	14
Short-Term Debt	192	0.00	96	0.00	-	-	-	25	7.75	0.00	-
Accounts Payable	2.13	6.72	2.94	0.03	0.07	0.01	0.01	0.60	0.13	0.82	1.06
Accrued Expenses	30	20	-	-	-	-	-	-	-	-	-
Current Deferred Revenue	1.13	1.28	2.09	0.00	-	-	-	-	0.89	0.89	1.08
Current Employee Benefit Liabilities	7.38	7.02	8.02	0.62	0.49	0.65	0.47	1.72	2.36	1.66	1.96
Other Current Nonoperating Liabilities	3.42	3.42	4.36	4.15	4.15	4.15	4.26	5.92	7.83	7.91	7.55
Total Noncurrent Liabilities	374	530	531	395	386	377	383	575	712	738	731
Long-Term Debt	256	446	444	395	386	377	383	574	708	733	726
Noncurrent Deferred Revenue	53	12	-	-	-	-	-	-	2.21	3.10	3.79
Noncurrent Deferred & Payable Income Tax Liabilities	0.00	0.56	5.77	-	-	-	-	-	-	-	-
Other Noncurrent Operating Liabilities	64	72	81	0.00	0.11	0.22	0.59	0.94	1.38	1.86	1.82
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	691	675	566	526	608	342	159	-243	-353	-343	-223
Total Preferred & Common Equity	691	675	566	415	540	313	154	-243	-353	-343	-223
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	691	675	566	415	540	313	154	-243	-353	-343	-223
Common Stock	693	1,094	1,165	1,265	1,262	1,260	1,257	1,259	1,283	1,353	1,454
Retained Earnings	-1.80	-25	-205	-456	-722	-946	-1,104	-1,499	-1,633	-1,692	-1,674
Treasury Stock	0.00	-394	-394	-	-	-	-	-	-	-	-3.26

This table presents Innoviva's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	1,254	1,232	1,225	1,268	1,188	1,118	1,130	1,328
Total Current Assets	582	401	358	311	305	324	296	455
Cash & Equivalents	319	261	217	178	180	173	144	301
Short-Term Investments	128	-	-	-	-	-	-	0.28
Note & Lease Receivable	61	61	67	62	57	66	60	-
Accounts Receivable	17	31	27	14	11	15	15	72
Inventories, net	41	34	37	37	41	47	50	71
Prepaid Expenses	15	13	8.48	17	15	21	24	7.93
Other Current Assets	0.31	2.05	2.15	2.99	1.99	2.14	2.82	2.43
Plant, Property, & Equipment, net	0.48	0.54	0.43	0.32	0.36	0.16	0.18	0.17
Total Noncurrent Assets	672	830	866	956	883	795	833	873
Long-Term Investments	330	508	536	628	422	398	456	489
Goodwill	18	18	18	18	18	15	28	16
Intangible Assets	202	211	217	224	237	243	248	258
Noncurrent Deferred & Refundable Income Taxes	12	15	11	-	4.95	6.33	-	0.00
Other Noncurrent Operating Assets	110	79	83	86	201	132	101	109
Total Liabilities & Shareholders' Equity	1,254	1,232	1,225	1,268	1,188	1,118	1,130	1,328
Total Liabilities	607	563	559	564	561	563	568	686
Total Current Liabilities	235	224	28	30	36	39	38	164
Short-Term Debt	192	192	-	-	0.00	0.00	0.00	96
Accounts Payable	4.70	4.17	2.04	0.89	3.78	4.59	5.93	3.81
Accrued Expenses	31	18	-	-	-	-	-	-
Current Deferred Revenue	1.00	0.72	0.86	0.99	1.55	3.25	2.09	2.85
Current Deferred & Payable Income Tax Liabilities	1.54	2.62	-	-	0.15	0.15	0.15	34
Current Employee Benefit Liabilities	3.79	5.97	4.76	3.42	5.17	5.47	4.22	6.47
Other Current Nonoperating Liabilities	0.83	0.83	3.42	0.83	0.83	3.42	0.83	5.70
Total Noncurrent Liabilities	373	339	531	534	524	524	530	522
Long-Term Debt	257	256	447	447	446	445	445	444
Noncurrent Deferred Revenue	54	12	-	-	-	-	-	-
Other Noncurrent Operating Liabilities	62	71	72	72	79	69	70	78
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	647	669	666	704	627	555	561	641
Total Preferred & Common Equity	647	669	666	704	627	555	0.00	641
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	647	669	666	704	627	555	561	641
Common Stock	695	691	689	1,086	1,108	1,118	1,125	1,172
Retained Earnings	-48	-22	-23	11	-87	-169	-170	-137
Other Equity Adjustments	0.00	-	-	-	-	-	-	-

This table displays calculated financial ratios and metrics derived from Innoviva's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	15.54%	-6.30%	-15.45%	16.35%	29.03%	0.00%	20.16%	62.63%	147.58%	539.74%	86.08%
EBITDA Growth	-64.96%	-30.54%	-30.25%	23.59%	48.16%	4.55%	29.89%	52.45%	155.32%	340.27%	-50.62%
EBIT Growth	-79.51%	-37.72%	-31.45%	24.65%	50.82%	5.79%	31.71%	58.40%	240.87%	187.90%	-68.61%
NOPAT Growth	-85.49%	-23.80%	-36.30%	25.34%	52.47%	-56.12%	150.78%	68.73%	392.24%	193.08%	17.52%
Net Income Growth	-86.98%	-18.41%	-40.28%	25.53%	53.84%	-53.00%	202.62%	12.77%	734.71%	88.86%	1.31%
EPS Growth	-83.64%	-7.17%	-17.42%	42.08%	41.26%	-59.49%	201.71%	120.75%	431.25%	89.33%	10.18%
Operating Cash Flow Growth	33.76%	-30.07%	-44.55%	16.19%	21.62%	15.18%	57.69%	132.44%	501.95%	107.75%	-0.87%
Free Cash Flow Firm Growth	-73.97%	239.49%	-85.02%	24.92%	41.06%	-0.73%	53.97%	71.57%	165.32%	120.57%	-63.36%
Invested Capital Growth	-9.09%	-11.13%	73.98%	-23.47%	-16.05%	-13.62%	84.70%	5.90%	4.44%	-6.79%	232.62%
Revenue Q/Q Growth	1.69%	6.90%	-11.22%	4.59%	4.50%	-1.47%	4.12%	13.54%	18.42%	40.52%	223.85%
EBITDA Q/Q Growth	-31.94%	84.82%	-40.95%	14.05%	18.62%	-1.52%	4.30%	17.76%	19.64%	68.81%	-10,338.00%
EBIT Q/Q Growth	-48.89%	114.88%	-42.79%	14.72%	19.76%	-1.52%	4.83%	18.91%	23.35%	174.17%	-156.06%
NOPAT Q/Q Growth	-62.50%	159.42%	-46.04%	14.63%	19.88%	-52.63%	102.44%	18.56%	22.79%	119.05%	-128.29%
Net Income Q/Q Growth	-63.78%	260.33%	-34.10%	-7.37%	6.20%	-52.53%	107.71%	-16.48%	210.36%	51.88%	16.79%
EPS Q/Q Growth	-49.30%	197.30%	-27.74%	-8.01%	3.06%	-57.31%	107.65%	31.46%	55.88%	50.00%	18.92%
Operating Cash Flow Q/Q Growth	15.97%	20.87%	-30.73%	3.74%	6.23%	2.03%	6.64%	23.29%	30.27%	825.72%	21.29%
Free Cash Flow Firm Q/Q Growth	-68.84%	9,040.18%	-77.25%	8.82%	20.61%	-2.91%	17.12%	12.40%	2.37%	1,169.56%	9.40%
Invested Capital Q/Q Growth	-3.55%	-21.51%	4.98%	-1.71%	-4.92%	-1.18%	96.90%	8.17%	3.63%	-4.60%	5.76%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	89.80%	86.27%	95.84%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
EBITDA Margin	22.98%	75.76%	102.19%	123.89%	116.63%	101.58%	97.16%	89.88%	95.88%	92.97%	-247.55%
Operating Margin	12.11%	65.19%	96.70%	118.95%	110.28%	94.39%	91.28%	84.53%	81.60%	58.54%	-402.34%
EBIT Margin	11.28%	63.59%	95.68%	118.03%	110.17%	94.25%	89.10%	81.29%	83.45%	60.61%	-441.14%
Profit (Net Income) Margin	6.52%	57.89%	66.48%	94.12%	87.24%	73.17%	155.68%	61.81%	89.15%	-34.77%	-1,997.68%
Tax Burden Percent	62.57%	92.59%	76.76%	82.83%	82.94%	82.01%	193.25%	100.00%	199.68%	100.00%	229.11%
Interest Burden Percent	92.42%	98.31%	90.51%	96.27%	95.47%	94.67%	90.41%	76.05%	53.50%	-57.37%	197.66%
Effective Tax Rate	37.43%	7.41%	23.24%	17.17%	17.06%	17.99%	-93.25%	0.00%	0.16%	0.00%	0.00%
Return on Invested Capital (ROIC)	7.70%	47.65%	75.00%	139.86%	89.90%	50.27%	138.53%	80.88%	50.42%	10.10%	-16.13%
ROIC Less NNEP Spread (ROIC-NNEP)	8.85%	51.04%	86.78%	145.80%	100.65%	42.97%	124.07%	71.48%	52.24%	1.96%	-148.40%
Return on Net Nonoperating Assets (RNNOA)	-4.27%	-18.68%	-34.65%	-74.80%	-28.04%	25.95%	-1,109.96%	-125.96%	-84.66%	-3.47%	-428.53%
Return on Equity (ROE)	3.42%	28.97%	40.35%	65.06%	61.86%	76.22%	-971.44%	-45.08%	-34.23%	6.63%	-444.65%
Cash Return on Invested Capital (CROIC)	17.22%	59.44%	21.00%	166.45%	107.35%	64.88%	79.03%	75.15%	46.07%	17.13%	-123.67%
Operating Return on Assets (OROA)	3.18%	15.95%	29.38%	48.03%	43.04%	38.65%	50.80%	47.32%	28.29%	7.03%	-6.19%
Return on Assets (ROA)	1.84%	14.52%	20.41%	38.30%	34.08%	30.01%	88.76%	35.98%	30.22%	-4.03%	-28.01%
Return on Common Equity (ROCE)	3.42%	28.97%	36.24%	54.78%	55.57%	71.03%	-1,036.71%	-45.09%	-34.23%	6.63%	-444.65%
Return on Equity Simple (ROE_SIMPLE)	3.38%	26.63%	38.93%	88.93%	54.42%	60.92%	264.57%	-55.29%	-33.73%	5.48%	75.43%
Net Operating Profit after Tax (NOPAT)	27	187	246	386	308	202	460	184	109	22	-24
NOPAT Margin	7.58%	60.37%	74.23%	98.53%	91.46%	77.40%	176.41%	84.52%	81.47%	40.98%	-281.64%
Net Nonoperating Expense Percent (NNEP)	-1.15%	-3.39%	-11.78%	-5.94%	-10.75%	7.30%	14.46%	9.40%	-1.82%	8.14%	132.28%
Return On Investment Capital (ROIC_SIMPLE)	2.39%	16.72%	22.23%	-	-	-	-	-	-	-	-
Cost of Revenue to Revenue	10.20%	13.73%	4.16%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	32.25%	31.64%	19.18%	4.13%	4.12%	5.62%	8.72%	14.85%	17.36%	36.61%	413.42%
R&D to Revenue	3.81%	10.93%	12.50%	0.15%	0.53%	0.00%	0.00%	0.62%	1.04%	4.85%	88.91%
Operating Expenses to Revenue	77.68%	21.07%	-0.86%	-18.95%	-10.28%	5.62%	8.72%	15.47%	18.40%	41.46%	502.34%
Earnings before Interest and Taxes (EBIT)	40	197	317	463	371	246	233	177	111	33	-37
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	82	235	339	485	393	265	254	195	128	50	-21
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.57	1.52	1.63	2.89	2.33	4.57	11.48	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	2.34	2.41	3.23	2.89	2.33	4.57	11.48	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	3.03	3.31	2.79	3.06	3.73	5.49	6.76	7.06	8.71	0.02	0.12
Price to Earnings (P/E)	46.43	5.72	4.32	4.51	5.60	9.12	4.46	11.43	9.77	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.15%	17.48%	23.14%	22.18%	17.86%	10.97%	22.41%	8.75%	10.23%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.16	1.94	1.85	4.26	3.28	4.00	4.72	8.58	7.84	2.59	1.96
Enterprise Value to Revenue (EV/Rev)	2.03	2.32	2.33	2.60	3.04	5.70	7.80	9.22	12.95	10.14	52.56
Enterprise Value to EBITDA (EV/EBITDA)	8.83	3.06	2.28	2.10	2.61	5.62	8.03	10.26	13.50	10.90	0.00
Enterprise Value to EBIT (EV/EBIT)	18.00	3.65	2.43	2.20	2.76	6.05	8.76	11.35	15.51	16.72	0.00
Enterprise Value to NOPAT (EV/NOPAT)	26.78	3.84	3.13	2.64	3.33	7.37	4.42	10.91	15.89	24.74	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	3.86	5.10	3.82	2.80	3.27	5.78	9.11	14.13	28.35	53.98	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	11.97	3.08	11.20	2.22	2.79	5.71	7.75	11.74	17.39	14.59	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.65	0.66	0.96	0.75	0.63	1.10	2.41	-2.47	-2.03	-2.14	-3.25
Long-Term Debt to Equity	0.37	0.66	0.79	0.75	0.63	1.10	2.41	-2.37	-2.01	-2.14	-3.25
Financial Leverage	-0.48	-0.37	-0.40	-0.51	-0.28	0.60	-8.95	-1.76	-1.62	-1.77	2.89
Leverage Ratio	1.86	1.99	1.98	1.70	1.82	2.54	-10.94	-1.25	-1.13	-1.64	15.88
Compound Leverage Factor	1.72	1.96	1.79	1.64	1.73	2.40	-9.89	-0.95	-0.61	0.94	31.38
Debt to Total Capital	39.35%	39.80%	48.85%	42.87%	38.81%	52.43%	70.65%	168.05%	197.22%	187.75%	144.47%
Short-Term Debt to Total Capital	16.85%	0.00%	8.70%	0.00%	0.00%	0.00%	0.00%	7.01%	2.13%	0.00%	0.00%
Long-Term Debt to Total Capital	22.49%	39.80%	40.16%	42.87%	38.81%	52.43%	70.65%	161.04%	195.08%	187.75%	144.47%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	12.08%	6.84%	3.98%	1.01%	0.04%	0.00%	0.00%	0.00%
Common Equity to Total Capital	60.65%	60.20%	51.15%	45.05%	54.35%	43.59%	28.34%	-68.09%	-97.22%	-87.75%	-44.47%
Debt to EBITDA	5.44	1.90	1.60	0.81	0.98	1.42	1.51	3.07	5.59	14.62	-34.76
Net Debt to EBITDA	-4.35	-1.31	-0.45	-0.60	-0.76	0.10	1.06	2.41	4.42	10.88	-21.19
Long-Term Debt to EBITDA	3.11	1.90	1.31	0.81	0.98	1.42	1.51	2.94	5.53	14.62	-34.76
Debt to NOPAT	16.49	2.38	2.20	1.02	1.25	1.87	0.83	3.26	6.58	33.16	-30.55
Net Debt to NOPAT	-13.17	-1.64	-0.62	-0.75	-0.97	0.13	0.58	2.56	5.20	24.69	-18.62
Long-Term Debt to NOPAT	9.43	2.38	1.81	1.02	1.25	1.87	0.83	3.13	6.51	33.16	-30.55
Altman Z-Score	1.74	2.13	2.02	3.58	2.88	2.61	2.20	-1.49	-3.19	-4.81	-4.16
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	10.19%	15.80%	10.16%	6.80%	-6.72%	-0.03%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.35	9.03	3.29	54.02	55.98	80.29	34.92	5.77	9.88	15.89	18.33
Quick Ratio	2.11	7.28	2.63	53.77	55.71	80.11	34.77	5.75	9.84	15.83	17.48
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	61	234	69	460	368	261	263	171	99	37	-182
Operating Cash Flow to CapEx	111,650.89%	34,322.14%	301,083.58%	0.00%	2,408,561.54%	2,145,483.33%	0.00%	0.00%	21,936.69%	144,728.57%	-23,811.11%
Free Cash Flow to Firm to Interest Expense	2.74	12.20	1.89	24.10	20.07	13.97	10.97	3.91	1.90	0.72	-4.94
Operating Cash Flow to Interest Expense	8.50	7.36	5.53	19.08	17.08	13.80	9.33	3.25	1.16	0.20	-3.54
Operating Cash Flow Less CapEx to Interest Expense	8.49	7.34	5.53	19.08	17.08	13.80	9.33	3.25	1.16	0.20	-3.56
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.28	0.25	0.31	0.41	0.39	0.41	0.57	0.58	0.34	0.12	0.01
Accounts Receivable Turnover	20.59	26.03	0.00	0.00	3.89	3.21	3.39	3.70	3.66	0.00	0.00
Inventory Turnover	0.98	0.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	719.58	950.88	3,641.09	19,593.30	11,042.43	2,704.83	1,414.66	752.92	453.55	197.98	1.60
Accounts Payable Turnover	8.27	8.83	9.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	17.73	14.02	0.00	0.00	93.94	113.77	107.56	98.63	99.84	0.00	0.00
Days Inventory Outstanding (DIO)	371.31	413.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	44.13	41.33	39.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	344.92	386.29	-39.24	0.00	93.94	113.77	107.56	98.63	99.84	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	336	370	416	239	313	373	431	234	220	211	226
Invested Capital Turnover	1.02	0.79	1.01	1.42	0.98	0.65	0.79	0.96	0.62	0.25	0.06
Increase / (Decrease) in Invested Capital	-34	-46	177	-73	-60	-59	198	13	9.38	-15	158
Enterprise Value (EV)	728	720	771	1,019	1,025	1,489	2,037	2,003	1,729	547	443
Market Capitalization	1,086	1,028	925	1,199	1,256	1,434	1,763	1,533	1,163	1.00	0.98
Book Value per Share	$11.04	$10.53	$8.11	$5.97	$5.33	$3.10	$1.52	($2.25)	($3.25)	($2.92)	($1.94)
Tangible Book Value per Share	$7.43	$6.66	$4.10	$5.97	$5.33	$3.10	$1.52	($2.25)	($3.25)	($2.92)	($1.94)
Total Capital	1,140	1,121	1,106	921	993	719	542	357	363	390	502
Total Debt	448	446	540	395	386	377	383	599	716	733	726
Total Long-Term Debt	256	446	444	395	386	377	383	574	708	733	726
Net Debt	-358	-308	-154	-291	-299	26	268	470	566	546	442
Capital Expenditures (CapEx)	0.17	0.41	0.07	0.00	0.01	0.01	0.00	0.00	0.28	0.01	0.55
Debt-free, Cash-free Net Working Capital (DFCFNWC)	98	113	114	106	89	75	78	62	35	14	-2.07
Debt-free Net Working Capital (DFNWC)	510	306	405	308	336	426	193	191	186	201	238
Net Working Capital (NWC)	318	306	309	308	336	426	193	166	178	201	238
Net Nonoperating Expense (NNE)	3.79	7.69	26	17	14	11	54	49	-10	41	145
Net Nonoperating Obligations (NNO)	-355	-305	-149	-287	-295	30	272	476	573	554	450
Total Depreciation and Amortization (D&A)	42	38	22	23	22	19	21	19	17	17	16
Debt-free, Cash-free Net Working Capital to Revenue	27.25%	36.26%	34.31%	27.14%	26.56%	28.74%	30.05%	28.34%	26.44%	25.12%	-24.57%
Debt-free Net Working Capital to Revenue	142.25%	98.59%	122.15%	78.56%	99.75%	163.16%	74.08%	87.76%	139.07%	372.27%	2,827.30%
Net Working Capital to Revenue	88.71%	98.59%	93.12%	78.56%	99.75%	163.16%	74.08%	76.25%	133.26%	372.27%	2,827.30%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.37	$0.00	$3.07	$0.00	$2.21	$1.55	$3.92	$1.25	$0.54	($0.16)	($1.50)
Adjusted Weighted Average Basic Shares Outstanding	62.73M	0.00	69.64M	0.00	101.32M	101.15M	100.85M	106.95M	110.28M	114.12M	116.62M
Adjusted Diluted Earnings per Share	$0.36	$0.00	$2.37	$0.00	$2.02	$1.43	$3.53	$1.17	$0.53	($0.16)	($1.50)
Adjusted Weighted Average Diluted Shares Outstanding	74.19M	0.00	95.25M	0.00	113.55M	113.41M	113.41M	119.87M	123.23M	114.12M	116.62M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$3.92	$1.25	$0.00	($0.16)	($1.50)
Adjusted Weighted Average Basic & Diluted Shares Outstanding	62.68M	0.00	68.13M	0.00	101.39M	101.30M	101.12M	101.82M	109.20M	115.37M	112.06M
Normalized Net Operating Profit after Tax (NOPAT)	27	187	246	386	308	202	167	184	109	22	-24
Normalized NOPAT Margin	7.58%	60.37%	74.23%	98.53%	91.46%	77.40%	63.90%	84.52%	81.47%	40.98%	-281.64%
Pre Tax Income Margin	10.42%	62.52%	86.60%	113.63%	105.18%	89.23%	80.56%	61.82%	44.64%	-34.77%	-871.93%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.82	10.31	8.70	24.25	20.24	13.18	9.71	4.05	2.13	0.63	-1.01
NOPAT to Interest Expense	1.22	9.78	6.75	20.25	16.80	10.83	19.22	4.21	2.08	0.43	-0.64
EBIT Less CapEx to Interest Expense	1.81	10.28	8.70	24.25	20.24	13.18	9.71	4.05	2.12	0.63	-1.02
NOPAT Less CapEx to Interest Expense	1.22	9.76	6.75	20.25	16.80	10.83	19.22	4.21	2.07	0.43	-0.66
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	31.69%	16.12%	10.37%	5.53%	1.49%	0.19%	0.81%	-465.52%	-198.58%
Augmented Payout Ratio	63.17%	42.14%	35.55%	122.98%	10.37%	5.53%	1.49%	72.81%	66.39%	-602.17%	-198.58%

This table displays calculated financial ratios and metrics derived from Innoviva's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	14.37%	6.95%	33.08%	23.34%	1.48%	30.45%	0.00%	-25.16%	-15.20%	-38.89%	-31.27%
EBITDA Growth	-166.16%	-53.07%	-81.73%	-270.21%	14.08%	307.82%	-67.18%	-43.51%	-2.49%	-117.55%	195.80%
EBIT Growth	-321.35%	-62.04%	-91.70%	-656.99%	10.36%	244.41%	-70.20%	-71.68%	-10.98%	-122.26%	208.18%
NOPAT Growth	38.81%	-69.41%	-98.28%	-1,438.99%	4.88%	323.24%	-64.04%	-92.47%	-8.53%	-117.97%	194.06%
Net Income Growth	-227.52%	-66.96%	-98.52%	-2,809.77%	4.78%	190.07%	-64.23%	-94.01%	-7.91%	-249.65%	123.43%
EPS Growth	-260.87%	-44.87%	-97.96%	-2,850.00%	9.52%	214.71%	-65.00%	-60.00%	110.00%	-395.65%	211.11%
Operating Cash Flow Growth	31.23%	78.13%	10.80%	14.50%	44.24%	273.70%	180.06%	-51.69%	-73.82%	-90.95%	-83.78%
Free Cash Flow Firm Growth	-35.85%	-51.66%	1,368.00%	145.08%	359.32%	153.40%	-89.23%	-178.93%	-465.12%	-188.79%	-52.17%
Invested Capital Growth	-7.14%	-9.09%	-26.02%	-16.17%	-15.38%	-11.13%	18.87%	30.53%	22.95%	73.98%	62.89%
Revenue Q/Q Growth	-3.46%	2.57%	-10.40%	28.90%	-9.72%	27.63%	-16.96%	6.05%	16.06%	-2.16%	-37.85%
EBITDA Q/Q Growth	-142.00%	93.44%	166.69%	-146.47%	-19.40%	-24.67%	521.12%	-68.85%	242.61%	-111.90%	969.28%
EBIT Q/Q Growth	-205.03%	230.84%	119.37%	-179.33%	-22.72%	-27.68%	1,199.88%	-84.28%	197.72%	-114.92%	1,135.32%
NOPAT Q/Q Growth	49.57%	1,256.61%	105.68%	-165.06%	-38.93%	-23.92%	4,329.60%	-94.90%	229.98%	-112.25%	827.60%
Net Income Q/Q Growth	-329.12%	1,576.17%	103.50%	-194.94%	-40.63%	-25.00%	6,309.84%	-96.33%	151.04%	-129.79%	973.17%
EPS Q/Q Growth	-272.09%	2,050.00%	103.64%	-219.57%	-41.03%	-20.41%	4,800.00%	-95.24%	161.76%	-124.29%	5,500.00%
Operating Cash Flow Q/Q Growth	-17.93%	21.68%	11.36%	18.01%	11.40%	-24.32%	15.09%	48.66%	188.62%	-43.28%	-80.15%
Free Cash Flow Firm Q/Q Growth	1.02%	-57.28%	177.23%	-55.81%	-7.65%	1,197.51%	108.51%	-154.20%	80.98%	-361.65%	320.53%
Invested Capital Q/Q Growth	-4.93%	-3.55%	-3.84%	5.31%	-6.93%	-21.51%	8.97%	6.30%	-2.25%	4.98%	19.66%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	82.72%	92.20%	88.84%	91.52%	85.84%	84.70%	84.86%	88.91%	86.45%	84.63%	94.53%
EBITDA Margin	-16.21%	37.25%	19.75%	-26.54%	73.62%	84.90%	143.84%	19.23%	65.48%	-53.29%	438.34%
Operating Margin	46.74%	25.65%	9.02%	-36.01%	61.69%	73.45%	129.77%	10.53%	57.02%	-61.64%	430.23%
EBIT Margin	-28.06%	25.79%	7.99%	-36.99%	60.10%	72.65%	128.21%	8.19%	55.26%	-65.63%	430.27%
Profit (Net Income) Margin	-52.56%	22.15%	1.36%	-34.72%	47.14%	71.68%	121.99%	1.58%	45.65%	-103.82%	341.00%
Tax Burden Percent	120.72%	82.34%	17.71%	88.30%	80.96%	100.54%	95.46%	22.05%	84.75%	105.61%	80.07%
Interest Burden Percent	155.18%	104.30%	95.71%	106.30%	96.88%	98.13%	99.67%	87.50%	97.48%	149.79%	98.98%
Effective Tax Rate	0.00%	17.66%	82.29%	0.00%	19.04%	-0.54%	4.54%	77.95%	15.25%	0.00%	19.93%
Return on Invested Capital (ROIC)	36.43%	21.44%	1.37%	-20.95%	41.41%	58.29%	82.87%	1.76%	41.59%	-43.60%	401.63%
ROIC Less NNEP Spread (ROIC-NNEP)	58.46%	21.16%	1.46%	-16.48%	42.26%	59.11%	83.50%	2.10%	42.67%	-25.28%	402.59%
Return on Net Nonoperating Assets (RNNOA)	-29.70%	-10.21%	-0.54%	5.74%	-17.16%	-21.64%	-26.36%	-0.67%	-14.39%	10.10%	-175.13%
Return on Equity (ROE)	6.73%	11.23%	0.84%	-15.21%	24.26%	36.66%	56.51%	1.10%	27.20%	-33.51%	226.51%
Cash Return on Invested Capital (CROIC)	19.85%	17.22%	47.59%	56.34%	67.03%	59.44%	-0.60%	31.29%	45.12%	21.00%	94.53%
Operating Return on Assets (OROA)	-8.23%	7.27%	2.33%	-10.43%	15.62%	18.23%	29.60%	2.11%	15.69%	-20.15%	145.00%
Return on Assets (ROA)	-15.42%	6.24%	0.40%	-9.79%	12.25%	17.98%	28.16%	0.41%	12.96%	-31.88%	114.92%
Return on Common Equity (ROCE)	6.73%	11.23%	0.84%	-15.21%	24.26%	36.66%	56.51%	0.92%	23.16%	-30.09%	208.72%
Return on Equity Simple (ROE_SIMPLE)	-9.23%	0.00%	9.66%	21.85%	25.78%	0.00%	7.95%	35.52%	0.00%	0.00%	52.11%
Net Operating Profit after Tax (NOPAT)	29	19	1.43	-25	39	63	83	1.88	37	-28	232
NOPAT Margin	32.72%	21.12%	1.60%	-25.21%	49.95%	73.84%	123.87%	2.32%	48.32%	-43.15%	344.49%
Net Nonoperating Expense Percent (NNEP)	-22.03%	0.29%	-0.09%	-4.47%	-0.85%	-0.82%	-0.63%	-0.34%	-1.09%	-18.32%	-0.95%
Return On Investment Capital (ROIC_SIMPLE)	2.65%	1.70%	-	-	-	5.65%	-	-	-	-2.57%	-
Cost of Revenue to Revenue	17.28%	7.80%	11.16%	8.48%	14.16%	15.30%	15.14%	11.09%	13.55%	15.37%	5.47%
SG&A Expenses to Revenue	31.02%	34.12%	29.29%	27.77%	39.23%	30.66%	42.58%	29.07%	25.84%	26.52%	41.35%
R&D to Revenue	4.96%	3.99%	3.97%	2.56%	5.00%	2.74%	5.93%	18.51%	16.48%	15.17%	17.43%
Operating Expenses to Revenue	35.98%	66.54%	79.82%	127.53%	24.15%	11.26%	-44.91%	78.38%	29.43%	146.27%	-335.70%
Earnings before Interest and Taxes (EBIT)	-25	24	7.16	-37	47	62	86	6.63	42	-43	289
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-14	34	18	-27	57	73	97	16	50	-35	295
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.76	1.57	1.81	1.54	1.37	1.52	1.35	1.50	1.37	1.63	1.26
Price to Tangible Book Value (P/TBV)	2.66	2.34	2.75	2.38	2.09	2.41	2.27	2.81	2.69	3.23	2.21
Price to Revenue (P/Rev)	3.07	3.03	3.42	3.10	3.09	3.31	2.91	2.87	2.41	2.79	2.17
Price to Earnings (P/E)	0.00	46.43	18.70	7.04	5.31	5.72	16.95	3.57	3.29	4.32	2.77
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	2.15%	5.35%	14.20%	18.82%	17.48%	5.90%	27.98%	30.40%	23.14%	36.15%
Enterprise Value to Invested Capital (EV/IC)	2.53	2.16	2.54	1.98	1.75	1.94	1.46	1.64	1.50	1.85	1.41
Enterprise Value to Revenue (EV/Rev)	2.19	2.03	2.52	2.17	1.94	2.32	2.37	2.44	1.92	2.33	1.50
Enterprise Value to EBITDA (EV/EBITDA)	17.44	8.83	7.33	3.59	2.49	3.06	5.41	2.18	1.81	2.28	0.97
Enterprise Value to EBIT (EV/EBIT)	185.64	18.00	11.21	4.54	2.99	3.65	7.50	2.40	1.96	2.43	1.01
Enterprise Value to NOPAT (EV/NOPAT)	19.55	26.78	12.24	4.66	3.19	3.84	9.54	3.21	2.52	3.13	1.23
Enterprise Value to Operating Cash Flow (EV/OCF)	4.04	3.86	5.45	4.55	3.96	5.10	5.90	8.01	4.73	3.82	1.92
Enterprise Value to Free Cash Flow (EV/FCFF)	12.26	11.97	4.55	3.20	2.40	3.08	0.00	5.92	3.67	11.20	1.85
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.69	0.65	0.67	0.67	0.63	0.66	0.71	0.80	0.79	0.96	0.84
Long-Term Debt to Equity	0.40	0.37	0.38	0.67	0.63	0.66	0.71	0.80	0.79	0.79	0.69
Financial Leverage	-0.51	-0.48	-0.37	-0.35	-0.41	-0.37	-0.32	-0.32	-0.34	-0.40	-0.44
Leverage Ratio	1.87	1.86	1.87	1.92	1.89	1.99	1.98	2.01	2.01	1.98	1.95
Compound Leverage Factor	2.90	1.94	1.79	2.04	1.84	1.96	1.98	1.76	1.96	2.96	1.93
Debt to Total Capital	40.96%	39.35%	40.11%	40.19%	38.83%	39.80%	41.53%	44.51%	44.20%	48.85%	45.70%
Short-Term Debt to Total Capital	17.54%	16.85%	17.18%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	8.70%	8.14%
Long-Term Debt to Total Capital	23.42%	22.49%	22.93%	40.19%	38.83%	39.80%	41.53%	44.51%	44.20%	40.16%	37.56%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	59.04%	60.65%	59.89%	59.81%	61.17%	60.20%	58.47%	55.49%	55.80%	51.15%	54.30%
Debt to EBITDA	9.69	5.44	3.70	2.23	1.84	1.90	3.50	1.37	1.32	1.60	0.94
Net Debt to EBITDA	-7.07	-4.35	-2.65	-1.53	-1.49	-1.31	-1.23	-0.39	-0.46	-0.45	-0.44
Long-Term Debt to EBITDA	5.54	3.11	2.11	2.23	1.84	1.90	3.50	1.37	1.32	1.31	0.77
Debt to NOPAT	10.85	16.49	6.18	2.90	2.36	2.38	6.17	2.02	1.83	2.20	1.18
Net Debt to NOPAT	-7.93	-13.17	-4.42	-1.99	-1.90	-1.64	-2.17	-0.57	-0.64	-0.62	-0.55
Long-Term Debt to NOPAT	6.21	9.43	3.53	2.90	2.36	2.38	6.17	2.02	1.83	1.81	0.97
Altman Z-Score	1.63	1.70	1.74	1.57	1.67	1.77	1.56	1.26	1.28	1.05	1.83
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	15.81%	14.87%	10.19%	7.85%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.48	2.35	1.79	12.70	10.42	9.03	8.43	8.21	7.77	3.29	2.77
Quick Ratio	2.24	2.11	1.57	11.03	8.51	7.28	6.85	6.45	5.76	2.63	2.28
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	54	53	124	45	101	110	8.46	-99	-39	-205	79
Operating Cash Flow to CapEx	0.00%	0.00%	18,031.85%	0.00%	0.00%	22,023.84%	19,357.71%	0.00%	77,830.30%	26,173.53%	142,636.36%
Free Cash Flow to Firm to Interest Expense	11.37	11.17	21.38	7.72	17.32	18.44	1.92	-22.67	-8.83	-8.32	15.41
Operating Cash Flow to Interest Expense	10.32	12.47	8.38	7.54	6.33	5.59	10.00	8.71	5.80	0.36	3.08
Operating Cash Flow Less CapEx to Interest Expense	10.32	12.47	8.34	7.54	6.35	5.56	9.94	8.71	5.79	0.36	3.08
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.29	0.28	0.29	0.28	0.26	0.25	0.23	0.26	0.28	0.31	0.34
Accounts Receivable Turnover	24.01	20.59	17.08	15.72	21.03	26.03	6.99	4.58	5.83	0.00	4.30
Inventory Turnover	0.87	0.98	1.14	1.02	0.99	0.88	0.71	0.00	0.00	0.00	0.00
Fixed Asset Turnover	916.59	719.58	779.55	1,124.14	1,236.47	950.88	1,104.28	1,723.58	1,712.41	3,641.09	4,146.84
Accounts Payable Turnover	12.34	8.27	10.70	12.90	12.68	8.83	10.44	7.43	6.24	9.30	1.89
Days Sales Outstanding (DSO)	15.20	17.73	21.37	23.22	17.35	14.02	52.22	79.77	62.63	0.00	84.90
Days Inventory Outstanding (DIO)	417.41	371.31	320.51	356.46	367.39	413.60	512.74	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	29.57	44.13	34.10	28.30	28.78	41.33	34.95	49.12	58.52	39.24	193.11
Cash Conversion Cycle (CCC)	403.04	344.92	307.78	351.38	355.96	386.29	530.01	30.65	4.11	-39.24	-108.21
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	320	336	349	363	344	370	472	433	407	416	397
Invested Capital Turnover	1.11	1.02	0.86	0.83	0.83	0.79	0.67	0.76	0.86	1.01	1.17
Increase / (Decrease) in Invested Capital	-25	-34	-123	-70	-63	-46	75	101	76	177	153
Enterprise Value (EV)	808	728	888	718	604	720	689	708	611	771	559
Market Capitalization	1,136	1,086	1,208	1,024	964	1,028	846	834	766	925	809
Book Value per Share	$10.32	$11.04	$10.69	$10.66	$11.14	$10.53	$9.64	$8.47	$8.28	$8.11	$9.20
Tangible Book Value per Share	$6.81	$7.43	$7.03	$6.89	$7.31	$6.66	$5.73	$4.53	$4.21	$4.10	$5.26
Total Capital	1,096	1,140	1,116	1,113	1,150	1,121	1,073	1,000	1,006	1,106	1,181
Total Debt	449	448	448	447	447	446	446	445	445	540	540
Total Long-Term Debt	257	256	256	447	447	446	446	445	445	444	444
Net Debt	-328	-358	-321	-306	-360	-308	-157	-126	-155	-154	-250
Capital Expenditures (CapEx)	0.00	-0.00	0.27	0.00	-0.10	0.15	0.23	0.00	0.03	0.03	0.01
Debt-free, Cash-free Net Working Capital (DFCFNWC)	93	98	108	113	103	113	89	111	114	114	86
Debt-free Net Working Capital (DFNWC)	539	510	369	330	281	306	269	284	258	405	387
Net Working Capital (NWC)	347	318	177	330	281	306	269	284	258	309	291
Net Nonoperating Expense (NNE)	76	-0.94	0.22	9.50	2.18	1.86	1.27	0.60	2.04	40	2.35
Net Nonoperating Obligations (NNO)	-327	-355	-320	-303	-359	-305	-156	-122	-154	-149	-245
Total Depreciation and Amortization (D&A)	11	11	11	10	10	11	11	8.94	7.81	8.12	5.43
Debt-free, Cash-free Net Working Capital to Revenue	25.04%	27.25%	30.64%	34.21%	33.09%	36.26%	30.58%	38.26%	35.97%	34.31%	22.98%
Debt-free Net Working Capital to Revenue	145.87%	142.25%	104.53%	99.87%	90.33%	98.59%	92.56%	97.84%	81.32%	122.15%	103.65%
Net Working Capital to Revenue	93.90%	88.71%	50.14%	99.87%	90.33%	98.59%	92.56%	97.84%	81.32%	93.12%	77.89%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.74)	$0.32	$0.02	($0.55)	$0.58	$0.96	$1.26	$0.02	$0.51	($0.98)	$3.81
Adjusted Weighted Average Basic Shares Outstanding	62.71M	62.73M	62.57M	62.53M	63.19M	65.44M	64.95M	65.34M	67.79M	69.64M	69.73M
Adjusted Diluted Earnings per Share	($0.74)	$0.43	$0.02	($0.55)	$0.46	$0.78	$0.98	$0.02	$0.42	($0.68)	$2.80
Adjusted Weighted Average Diluted Shares Outstanding	62.71M	74.19M	62.95M	62.53M	84.53M	86.88M	86.16M	65.49M	89.79M	95.25M	95.83M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	62.78M	62.68M	62.60M	62.56M	62.44M	63.23M	64.09M	65.10M	65.50M	68.13M	69.78M
Normalized Net Operating Profit after Tax (NOPAT)	29	19	5.65	-25	39	44	83	5.97	37	-28	232
Normalized NOPAT Margin	32.72%	21.12%	6.31%	-25.21%	49.95%	51.41%	123.87%	7.37%	48.32%	-43.15%	344.49%
Pre Tax Income Margin	-43.54%	26.90%	7.65%	-39.32%	58.23%	71.30%	127.79%	7.17%	53.87%	-98.31%	425.87%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-5.28	4.99	1.23	-6.37	7.96	10.48	19.62	1.51	9.53	-1.75	56.79
NOPAT to Interest Expense	6.16	4.08	0.25	-4.34	6.62	10.65	18.95	0.43	8.34	-1.15	45.47
EBIT Less CapEx to Interest Expense	-5.28	4.99	1.19	-6.37	7.98	10.45	19.56	1.51	9.53	-1.75	56.78
NOPAT Less CapEx to Interest Expense	6.16	4.08	0.20	-4.34	6.63	10.62	18.90	0.43	8.33	-1.15	45.46
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	31.69%	24.81%
Augmented Payout Ratio	-8.72%	63.17%	45.54%	27.84%	24.57%	42.14%	139.53%	29.68%	22.66%	35.55%	24.81%

Frequently Asked Questions About Innoviva's Financials

When does Innoviva's fiscal year end?

According to the most recent income statement we have on file, Innoviva's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Innoviva's net income changed over the last 10 years?

Innoviva's net income appears to be on an upward trend, with a most recent value of $23.39 million in 2024, falling from -$168.46 million in 2014. The previous period was $179.72 million in 2023. View Innoviva's forecast to see where analysts expect Innoviva to go next.

What is Innoviva's operating income?

Innoviva's total operating income in 2024 was $43.45 million, based on the following breakdown:

Total Gross Profit: $322.11 million
Total Operating Expenses: $278.66 million

How has Innoviva revenue changed over the last 10 years?

Over the last 10 years, Innoviva's total revenue changed from $8.43 million in 2014 to $358.71 million in 2024, a change of 4,153.7%.

How much debt does Innoviva have?

Innoviva's total liabilities were at $609.90 million at the end of 2024, a 7.3% increase from 2023, and a 18.1% decrease since 2014.

How much cash does Innoviva have?

In the past 10 years, Innoviva's cash and equivalents has ranged from $62.42 million in 2018 to $304.96 million in 2024, and is currently $304.96 million as of their latest financial filing in 2024.

How has Innoviva's book value per share changed over the last 10 years?

Over the last 10 years, Innoviva's book value per share changed from -1.94 in 2014 to 11.04 in 2024, a change of -670.3%.

Related Companies

This page (NASDAQ:INVA) was last updated on 5/30/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Innoviva (INVA) Financials

Frequently Asked Questions About Innoviva's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Innoviva (INVA) Financials

Annual Income Statements for Innoviva

Quarterly Income Statements for Innoviva

Annual Cash Flow Statements for Innoviva

Quarterly Cash Flow Statements for Innoviva

Annual Balance Sheets for Innoviva

Quarterly Balance Sheets for Innoviva

Annual Metrics And Ratios for Innoviva

Quarterly Metrics And Ratios for Innoviva

Frequently Asked Questions About Innoviva's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools